共 44 条
- [3] [Anonymous], 2017, Guidelines for the prevention and control of carbapenem-resistant Enterobacteriaceae, Acinetobacter baumannii and Pseudomonas aeruginosa in health care facilities
- [4] Carbapenemase-Producing Organisms: A Global Scourge [J]. CLINICAL INFECTIOUS DISEASES, 2018, 66 (08) : 1290 - 1297
- [6] Efficacy and Safety of Ceftazidime-Avibactam for the Treatment of Carbapenem-Resistant Enterobacterales Bloodstream Infection: a Systematic Review and Meta-Analysis [J]. MICROBIOLOGY SPECTRUM, 2022, 10 (02):
- [7] CLSI, 2023, PERFORMANCE STANDARD, pM100
- [8] Control CfD Prevention, 2015, FACILITY GUIDANCE CO
- [9] Molecular characterization of Carbapenem resistant Escherichia coli recovered from a tertiary hospital in Lebanon [J]. PLOS ONE, 2018, 13 (09):
- [10] Davis SL, 2020, INVEST NEW DRUG, V38, P821, DOI [10.1007/s10637-019-00824-1, 10.1038/s41564-019-0492-8]